Sprinter Health just raised $32M to send full time nurses into people's homes for blood draws and vitals, and the pitch is not convenience, it is completion.
Health systems have spent years building better screening protocols and better outreach campaigns. Almost none of that investment matters if the patient told to get a blood draw simply never does it, and that gap between "ordered" and "completed" is exactly where Sprinter Health has built its business.
A funded bet on logistics, not information
Sprinter Health closed a $32 million Series B, led by Andreessen Horowitz and Accel, to expand a model built around one specific failure point: patients who are told to complete a lab draw or a check-in visit, and never do. The company sends full time nurses directly into homes to complete the task on the spot, rather than asking the patient to travel to a lab or a clinic.
That distinction matters more than it sounds. A missed lab draw does not show up as a dramatic failure anywhere in a health system's dashboard, it just quietly disappears, and the care plan built around that data point either stalls or proceeds on incomplete information. Sprinter's entire model exists because that quiet failure point turned out to be large enough, and expensive enough downstream, to fund a nine-figure category around fixing it.
Follow through is a different problem than access
Telehealth solved for distance. Sprinter is solving for follow through, which is a genuinely different failure point, and one that shows up specifically in preventive screening and chronic disease monitoring programs where a missed draw quietly kills the whole care plan before it even starts.
The hardest part of most care programs is not diagnosis or treatment, it is getting the patient to actually show up for the appointment that makes either possible, and that is as true of a Medicare wellness visit as it is of the biomarker testing platforms covered elsewhere in this issue.
This also reframes site of care innovation as a completion problem rather than purely an access problem. A patient can have full insurance coverage, a nearby lab, and a clear referral, and still never complete the draw, simply because the logistics of getting there never lined up with their week. Sprinter's model removes that logistics step entirely by moving the service to the patient instead.
Infrastructure or service
The model only works at the density and cost structure Sprinter has built if health systems and payers start treating it as core infrastructure rather than a pilot program layered on top of an existing workflow. Watch whether this raise is used to expand geographic density in existing markets, or to prove the model works as a white label layer other care programs, including some of the preventive screening platforms discussed later in this issue, can plug into directly.
That decision shapes whether Sprinter becomes a category defining platform other companies build on, or a well funded regional service competing market by market. Either path is viable, but they require very different next moves from here.
